Dianthus Therapeutics, Inc. (DNTH)
(Delayed Data from NSDQ)
$28.00 USD
+0.54 (1.97%)
Updated Oct 4, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.59 |
EPS Last Quarter | -0.51 |
Last EPS Surprise | -2.00% |
ABR | 1.09 |
Earnings ESP
|
15.66% |
---|---|
Current Year | -2.28 |
Next Year | -2.77 |
EPS (TTM) | -5.54 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.07M | 1.07M | 4.16M | 4.63M |
# of Estimates | 4 | 4 | 6 | 4 |
High Estimate | 1.86M | 1.86M | 6.46M | 7.45M |
Low Estimate | 0.50M | 0.50M | 2.70M | 2.00M |
Year ago Sales | 0.92M | 0.46M | 2.83M | 4.16M |
Year over Year Growth Est. | 16.52% | 133.04% | 47.03% | 11.31% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.59 | -0.65 | -2.28 | -2.77 |
# of Estimates | 7 | 7 | 8 | 7 |
Most Recent Consensus | -0.53 | -0.73 | -2.33 | -3.36 |
High Estimate | -0.50 | -0.49 | -1.84 | -2.32 |
Low Estimate | -0.73 | -0.78 | -2.58 | -3.36 |
Year ago EPS | -3.78 | -0.71 | -8.45 | -2.28 |
Year over Year Growth Est. | 84.39% | 8.45% | 73.02% | -21.50% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 3 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 4 | 3 | 4 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.59 | -0.65 | -2.28 | -2.77 |
7 Days Ago | -0.61 | -0.68 | -2.32 | -2.75 |
30 Days Ago | -0.61 | -0.68 | -2.32 | -2.75 |
60 Days Ago | -0.55 | -0.63 | -2.18 | -2.46 |
90 Days Ago | -0.55 | -0.63 | -2.18 | -2.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.49 | -2.03 | -2.92 |
Zacks Consensus Estimate | -0.59 | -0.65 | -2.28 | -2.77 |
Earnings ESP | 15.66% | 25.11% | 11.02% | -5.36% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.51 | -0.54 | -0.71 | -3.78 | NA |
Estimate | -0.50 | -0.43 | -1.11 | -0.51 | NA |
Difference | -0.01 | -0.11 | 0.40 | -3.27 | -0.75 |
Surprise | -2.00% | -25.58% | 36.04% | -641.18% | -158.18% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more